New research appearing in the journal Nature Biotechnology answers important questions about the viability of treatments that seek to replace diseased and aged cells in the central nervous system with healthy ones.
Opinion | Is Cholesterol Denialism Pseudoscience or Appropriate Medical Care?
Abramson is a retired family medicine physician and has served as expert in pharmaceutical litigation. Kaplan is a researcher and an expert in clinical research